The quarter cleared a modest market bar. Published estimates were roughly $92.1 million for revenue and $0.14 for GAAP EPS; STAAR delivered $93.5 million and $0.16, respectively, making this a narrow beat rather than a wholesale upside surprise.
| Metric | Q2 2026 | Q2 2025 | Read-through |
|---|---|---|---|
| Net sales | $93.5M (Financial Highlights) | $44.3M (Financial Highlights) | +111%, but against an inventory-disrupted base |
| Net sales excluding China | $41.2M (Financial Highlights) | $39.0M (Financial Highlights) | +6.0% (Financial Highlights) |
| China sales | $52.3M (Sales by Country) | $5.3M (Sales by Country) | Rebound from minimal shipments |
| Gross margin | 74.5% (Income Statement) | 74.0% (Income Statement) | +50 basis points |
| GAAP diluted EPS | $0.16 (Income Statement) | $(0.34) (Income Statement) | Recovered to profitability |
| Adjusted EBITDA | $20.0M (Non-GAAP reconciliation) | $(14.8)M (Non-GAAP reconciliation) | 21.4% margin (Non-GAAP reconciliation) |
| Operating cash flow | $19.7M (Cash Flow statement) | $(27.2)M (Cash Flow statement) | Positive in Q2; $(2.0)M for the first half |
The 111% revenue growth is economically less impressive than it looks. Q2 2025 was depressed because distributors were working through excess China inventory, so the comparison is unusually easy. China supplied $52.3 million, more than half of total revenue, while sales excluding China rose only 6%. That makes the result a genuine normalization and likely market-share gain in China, but not yet evidence of broad-based acceleration. (Financial Highlights) (Sales by Country)
Profitability improved meaningfully, but mostly through volume recovery rather than dramatic margin expansion. Adjusted EBITDA swung to $20.0 million from a $14.8 million loss, while gross margin advanced only to 74.5% from 74.0%. Operating expenses excluding the prior-year restructuring and merger costs still increased 3.7%, and ERP amortization and implementation costs remain a drag. The operating leverage story is therefore improving, but the filing does not yet show a major structural margin breakout. (Income Statement) (Non-GAAP reconciliation)
The forward setup is constructive but not formally upgraded. Management did not provide a quantified guidance raise; it said third-quarter volumes should decline seasonally from the first-half peak, while still expecting strong year-over-year growth excluding last year’s one-time $25.9 million China order. It also expects fourth-quarter year-over-year growth. That supports continued momentum, but the next comparisons will be more demanding and the company remains heavily dependent on China. (Shareholder letter — China seasonality)
The net read is a narrow beat with a better underlying business, not a clean breakout quarter. EVO+ adoption, higher China ASPs, and distributor inventories returning to target improve confidence in the recovery. However, ex-China growth was modest and first-half operating cash flow remained slightly negative despite the earnings rebound, leaving the result better than expected but still dependent on converting China momentum into broader growth and sustainable cash generation. (Sales by Country) (Cash Flow statement)
Read the original 8-K on SEC EDGAR ↗